Practical Tips
  • For patients >75 years of age, the FRS is not well validated
  • Clinical judgement is required in consultation with the patient to determine the value of pharmacotherapy
  • One approach is extrapolation of modified FRS – identifies most subjects as intermediate- to high-risk, based on age
Among individuals 30-59 years of age without diabetes, the presence of a positive history of premature CVD (men <55 and women <65 years of age in first-degree relatives) increases an individual's calculated Framingham percent risk by approximately 2-fold. The 10-year Framingham risk percent doubled for family history of premature CVD will be referred to as the modified FRS.